Crossmark

ASO Visual Abstract: Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is Not Impacted by Hepatic Artery Infusion Chemotherapy

Crossref DOI link: https://doi.org/10.1245/s10434-025-17475-7

Published Online: 2025-05-27

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Choubey, Ankur P.

Chou, Joanne F.

Soares, Kevin C.

Wei, Alice C.

D’Angelica, Michael I.

Jarnagin, William R.

Gonen, Mithat

Balachandran, Vinod P.

Drebin, Jeffrey

Santos, Ernesto

Camacho, Juan C.

Kingham, T. Peter

Ridouani, Fourat
License Information

Text and Data Mining valid from 2025-05-27

Version of Record valid from 2025-05-27
More Information

Article History

First Online: 27 May 2025

Disclosure

: Dr. Alice Wei reports institutional clinical trial funding from Ipsen, DSMB membership, and Histosonics, and notes that Memorial Sloan Kettering has institutional financial interests relative BioNTech, Epistem Prognostics, and Clarity Pharmaceuticals. Dr. Jeffrey Drebin, ALNY and IONS, reports stock ownership purchased through a brokerage. The remaining authors have no conflicts of interest.

Document is current

Any future updates will be listed below